Our research projects

Dr Supriti Ghosh at The Institute of Cancer Research hopes to learn more about how to use tiny fragments of DNA from the blood to monitor rhabdomyosarcoma.

Dr Jodie Bojko at the University of Bristol hopes to understand how genetic instructions are altered in neuroblastoma, and how this impacts the cancer.

Professor Shivaram Avula will identify markers in the brains of young people with brain tumours that will help predict the development of long-term side effects like learning and memory problems.

Professor Martin McCabe aims to understand whether blood-based biomarkers could help predict Ewing sarcoma survival.

Assessing rhabdomyosarcoma risk prediction markers based on the biological conditions in the tumour, like low oxygen levels, few blood vessels, and genetics.

Ependymoma comes back after treatment around half of the time, because some cancer cells are still alive. If doctors could identify these cells and diagnose relapsed ependymoma sooner, children could start treatment earlier.

Finding the biological differences between teenage and young adult cancers cells compared to older adults.

Identifying markers that can be used for a non-invasive test to diagnose and monitor Wilms tumour.

Looking for differences in newly diagnosed RMS patient samples to see if there are any that could be used to show whether treatments are working.